Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2009 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (212)	4/15/2009 9:43:37 PM
From: Arthur Radley	Respond to of 418

Wilder, Concerning DNDN, it appears that Georgia is going to zoom to the top and leave us all in the dust. PGO will be right behind him,only because of original allocation... Georgia picked up 10,000 shares, PGO only went for 5,000. Congrats to Georgia....!!!

To: keokalani'nui who wrote (212)	4/15/2009 9:51:52 PM
From: BulbaMan	Respond to of 418

Technet, thanks for the heads up! I'll try to do the CVTX reallocation after Friday's close. Wilder, I've been using the original dollar allocations and quotes after the deal actually closes to calculate buyout reallocations. I'll post your new share numbers later this evening.

To: keokalani'nui who wrote (212)	4/16/2009 2:30:04 AM
From: BulbaMan	Read Replies (2) \| Respond to of 418

Wilder, Here's what I have for your post-DNA share allocations: ARNA 1,656.99 ARYX 8,491.19 BIIB 259.87 DSCO 5,410.18 GTXI 843.85 NBIX 7,646.41 POZN 2,335.67 As you can see, my numbers are a bit different from yours but not significantly so. And, yeah, DNDN has propelled Georgia's portfolio to the No. 1 position.